跳至主要内容
临床试验/JPRN-UMIN000029669
JPRN-UMIN000029669
已完成
未知

The prospective exploratory study of safety and efficacy on the patients post-penetrating keratoplasty of topical tacrolimus 0.1%. - Inhibitory effect of topical tacrolimus 0.1% on the rejection of corneal graft.

Tokyo Dental Collage Ichikawa General Hospital0 个研究点目标入组 30 人2017年11月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Penetrating keratoplasty (PKP)
发起方
Tokyo Dental Collage Ichikawa General Hospital
入组人数
30
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2017年11月1日
结束日期
2021年3月31日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Tokyo Dental Collage Ichikawa General Hospital

入排标准

入选标准

  • 未提供

排除标准

  • 1\) Patients with allergic history against tavrolimus ophthalmic susupension 2\) Patients with infectious eye disease 3\) Patients with allergic history against betamethasone or fluorometholone ey drop 4\) Diabetic patients with poor glycemic control 5\) Glaucoma patients with poor IOP control 6\) Patients with severe infectious disease 7\) Patients with limbal transplantation 8\) Patients with cancer, severe liver dysfunction, severe renal dysfunction, severe cardiac disease, and other severe conditions 9\) Pregnant women, lactating women, may possibly be pregnant women 10\) Patients whom the prior treatment with topical or systemic use of steroid or immunosuppressant within 4 week before initiation 11\) Patients whom are expected to need a contraindicated durg use or therapy in the study period 12\) Patients whom are considered unsuitable by doctor in charge

结局指标

主要结局

未指定

相似试验